GLOBAL CALCIUM PRIVATE LTD

Overview

GLOBAL CALCIUM PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 31 active FDA Type II Drug Master Files, covering CALCIUM ACETATE USP; CALCIUM GLUCONATE MONOHYDRATE FOR INJECTION; CALCIUM GLUCONATE USP (FOR INJECTION) MONOHYDRATE; CLOZAPINE USP; CUPRIC SULFATE USP; DIBASIC PATASSIUM PHOSPHATE USP.

API / Drug Master Files

GLOBAL CALCIUM PRIVATE LTD holds 31 active (31 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TOLPERISONE HYDROCHLORIDEActive2025-10-24
• CALCIUM GLUCONATE USP (FOR INJECTION) MONOHYDRATEActive2025-08-18
• DORZOLAMIDE HYDROCHLORIDE USPActive2024-07-25
• HYDROQUINONE USPActive2024-03-22
• FERRIC CARBOXY MALTOSEActive2024-03-18
• TOPIRAMATE USPActive2024-03-14
• MIDAZOLAM USPActive2024-03-14
• DIBASIC PATASSIUM PHOSPHATE USPActive2024-03-11
• PYRIDOSTIGMINE BROMIDE USPActive2024-03-11
• TIMOLOL MALEATE USPActive2024-03-11
• ESMOLOL HYDROCHLORIDE USPActive2023-12-27
• SODIUM GLYCEROPHOSPHATE HYDRATEDActive2023-11-10
• SODIUM BICARBONATE USPActive2023-09-26
• FOMEPIZOLEActive2023-07-27
• MONOBASIC POTASSIUM PHOSPHATE USPActive2023-05-29

Showing 15 of 31 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GLOBAL CALCIUM PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.